{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T12:33:57Z","timestamp":1769517237670,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.carrev.2020.01.016","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T21:53:36Z","timestamp":1579902816000},"page":"1285-1290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Meta-Analysis of Secondary Prevention of Cryptogenic Stroke"],"prefix":"10.1016","volume":"21","author":[{"given":"Babikir","family":"Kheiri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy F.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Osman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harsh","family":"Golwala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qais","family":"Radaideh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khidir","family":"Dalouk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric C.","family":"Stecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firas","family":"Zahr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babak","family":"Nazer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hind","family":"Rahmouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2020.01.016_bb0005","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S1474-4422(15)00132-5","article-title":"Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study","volume":"14","author":"Li","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.carrev.2020.01.016_bb0010","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJM199412013312211","article-title":"The risk of embolic stroke. Another piece of the puzzle","volume":"331","author":"Kistler","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2020.01.016_bb0015","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1474-4422(13)70310-7","article-title":"Embolic strokes of undetermined source: the case for a new clinical construct","volume":"13","author":"Hart","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.carrev.2020.01.016_bb0020","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jacc.2008.04.062","article-title":"Aortic atherosclerosis, hypercoagulability, and stroke the APRIS (Aortic Plaque and Risk of Ischemic Stroke) study","volume":"25","author":"Di Tullio","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2020.01.016_bb0025","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/0735-1097(94)90662-9","article-title":"Transesophageal echocardiography and carotid ultrasound in patients with cerebral ischemia: prevalence of findings and recurrent stroke risk","volume":"23","author":"Comess","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2020.01.016_bb0030","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.clineuro.2006.12.003","article-title":"Significance of aortic atheroma in elderly patients with ischemic stroke. A hospital-based study and literature review","volume":"109","author":"Sharifkazemi","year":"2007","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.carrev.2020.01.016_bb0035","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jstrokecerebrovasdis.2011.01.005","article-title":"Echocardiography for the detection of cardiac sources of embolism in patients with stroke or transient ischemic attack","volume":"21","author":"Zhang","year":"2012","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.carrev.2020.01.016_bb0040","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/STROKEAHA.114.007240","article-title":"Embolic strokes of undetermined source in the Athens stroke registry: a descriptive analysis","volume":"46","author":"Ntaios","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.carrev.2020.01.016_bb0045","series-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014"},{"key":"10.1016\/j.carrev.2020.01.016_bb0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5603\/CJ.a2018.0016","article-title":"Patent foramen ovale closure versus medical therapy after cryptogenic stroke: an updated meta-analysis of all randomized clinical trials","volume":"26","author":"Kheiri","year":"2019","journal-title":"Cardiol J"},{"key":"10.1016\/j.carrev.2020.01.016_bb0055","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/STROKEAHA.116.016414","article-title":"Embolic stroke of undetermined source: a systematic review and clinical update","volume":"48","author":"Hart","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.carrev.2020.01.016_bb0060","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1093\/eurheartj\/ehv252","article-title":"Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysis","volume":"36","author":"Kent","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2020.01.016_bb0065","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000092331","article-title":"Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death: subgroup analyses from the warfarin-aspirin recurrent stroke study","volume":"22","author":"Sacco","year":"2006","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.carrev.2020.01.016_bb0070","first-page":"94","article-title":"Comparison of medical treatments in cryptogenic stroke patients with patent foramen ovale: a randomized clinical trial","volume":"18","author":"Shariat","year":"2013","journal-title":"J Res Med Sci"},{"key":"10.1016\/j.carrev.2020.01.016_bb0075","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJMoa1813959","article-title":"Dabigatran for prevention of stroke after embolic stroke of undetermined source","volume":"380","author":"Diener","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2020.01.016_bb0080","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","article-title":"Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke","volume":"377","author":"S\u00f8ndergaard","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2020.01.016_bb0085","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","article-title":"Long-term outcomes of patent foramen ovale closure or medical therapy after stroke","volume":"377","author":"Saver","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2020.01.016_bb0090","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1161\/01.CIR.0000017498.88393.44","article-title":"Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study","volume":"105","author":"Homma","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2020.01.016_bb0095","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","article-title":"Percutaneous closure of patent foramen ovale in cryptogenic embolism","volume":"368","author":"Meier","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2020.01.016_bb0100","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S1474-4422(18)30319-3","article-title":"Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial","volume":"17","author":"Kasner","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.carrev.2020.01.016_bb0105","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1802686","article-title":"Rivaroxaban for stroke prevention after embolic stroke of undetermined source","volume":"378","author":"Hart","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2020.01.016_bb0110","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.jacc.2018.02.046","article-title":"Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO trial","volume":"71","author":"Lee","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2020.01.016_bb0115","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1009639","article-title":"Closure or medical therapy for cryptogenic stroke with patent foramen ovale","volume":"366","author":"Furlan","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2020.01.016_bb0120","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","article-title":"Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke","volume":"377","author":"Mas","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2020.01.016_bb0125","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","article-title":"Cryptogenic stroke and underlying atrial fibrillation","volume":"370","author":"Sanna","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2020.01.016_bb0130","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S1474-4422(17)30002-9","article-title":"Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AFRANDOMISED): an open-label randomised controlled trial","volume":"16","author":"Wachter","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.carrev.2020.01.016_bb0135","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1056\/NEJMoa1311376","article-title":"Atrial fibrillation in patients with cryptogenic stroke","volume":"370","author":"Gladstone","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2020.01.016_bb0140","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1001\/jamaneurol.2019.0617","article-title":"Recurrent stroke with rivaroxaban compared with aspirin according to predictors of atrial fibrillation: secondary analysis of the NAVIGATE ESUS randomized clinical trial","volume":"76","author":"Healey","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.carrev.2020.01.016_bb0145","first-page":"1","article-title":"Association of embolic sources with cause-specific functional outcomes among adults with cryptogenic stroke","volume":"e182953","author":"Kiyuna","year":"2018","journal-title":"JAMA Netw Open"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838920300257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838920300257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:18:58Z","timestamp":1761560338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838920300257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1553838920300257"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2020.01.016","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-Analysis of Secondary Prevention of Cryptogenic Stroke","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2020.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}